{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:41:02Z","timestamp":1791160862168,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0071258","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T02:53:02Z","timestamp":1376535182000},"page":"e71258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["The 18-kDa Translocator Protein (TSPO) Disrupts Mammary Epithelial Morphogenesis and Promotes Breast Cancer Cell Migration"],"prefix":"10.1371","volume":"8","author":[{"given":"Xiaoting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrclinonc.2010.192","article-title":"Breast cancer: challenges, controversies, breakthroughs","volume":"7","author":"L Hutchinson","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/erc.0.0100261","article-title":"How to target estrogen receptor-negative breast cancer?","volume":"10","author":"H Rochefort","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/modpathol.3800255","article-title":"Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis","volume":"18","author":"TC Putti","year":"2005","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.3747\/co.v18i4.738","article-title":"Triple-negative breast cancers: an updated review on treatment options","volume":"18","author":"KB Reddy","year":"2011","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"S Fulda","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2009.08.002","article-title":"Mitochondrial gateways to cancer","volume":"31","author":"L Galluzzi","year":"2010","journal-title":"Mol Aspects Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"V Papadopoulos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1021\/bi900854z","article-title":"Targeting and insertion of the cholesterol-binding translocator protein into the outer mitochondrial membrane","volume":"48","author":"MB Rone","year":"2009","journal-title":"Biochemistry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ceca.2006.11.004","article-title":"The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria","volume":"42","author":"T Azarashvili","year":"2007","journal-title":"Cell Calcium"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/glia.21091","article-title":"Translocator protein (18 kDa)\/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state","volume":"59","author":"J Choi","year":"2011","journal-title":"Glia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10863-008-9142-1","article-title":"VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis","volume":"40","author":"L Veenman","year":"2008","journal-title":"J Bioenerg Biomembr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1158\/1078-0432.CCR-03-0988","article-title":"Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival","volume":"10","author":"S Galiegue","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2010.06.013","article-title":"Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states","volume":"327","author":"A Batarseh","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1081\/RRS-120025210","article-title":"Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression","volume":"23","author":"Z Han","year":"2003","journal-title":"J Recept Signal Transduct Res"},{"key":"ref16","first-page":"831","article-title":"Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol","volume":"59","author":"M Hardwick","year":"1999","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0006-2952(00)00325-7","article-title":"Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines","volume":"60","author":"A Beinlich","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bcp.2006.10.025","article-title":"Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation","volume":"73","author":"W Li","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0006-2952(99)00093-3","article-title":"Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line","volume":"58","author":"I Carmel","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/excr.1998.4084","article-title":"PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection","volume":"241","author":"T Hirsch","year":"1998","journal-title":"Exp Cell Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2004.07.015","article-title":"Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1","volume":"41","author":"AP Sutter","year":"2004","journal-title":"J Hepatol"},{"key":"ref22","first-page":"1388","article-title":"Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo","volume":"62","author":"D Decaudin","year":"2002","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1046-2023(03)00032-X","article-title":"Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures","volume":"30","author":"J Debnath","year":"2003","journal-title":"Methods"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrc1695","article-title":"Modelling glandular epithelial cancers in three-dimensional cultures","volume":"5","author":"J Debnath","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10911-006-9030-4","article-title":"Illuminating the center: mechanisms regulating lumen formation and maintenance in mammary morphogenesis","volume":"11","author":"MJ Reginato","year":"2006","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(02)01001-2","article-title":"The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini","volume":"111","author":"J Debnath","year":"2002","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1083\/jcb.200304159","article-title":"Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner","volume":"163","author":"J Debnath","year":"2003","journal-title":"J Cell Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ncb0901-785","article-title":"ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini","volume":"3","author":"SK Muthuswamy","year":"2001","journal-title":"Nat Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1038\/sj.onc.1208907","article-title":"PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor","volume":"24","author":"RA Gonzalez-Polo","year":"2005","journal-title":"Oncogene"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth1015","article-title":"Three-dimensional culture models of normal and malignant breast epithelial cells","volume":"4","author":"GY Lee","year":"2007","journal-title":"Nat Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"22932","DOI":"10.1074\/jbc.274.33.22932","article-title":"Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells","volume":"274","author":"AH Boulares","year":"1999","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1038\/onc.2010.198","article-title":"MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells","volume":"29","author":"J Chen","year":"2010","journal-title":"Oncogene"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-811X-9-17","article-title":"A novel MCF-10A line allowing conditional oncogene expression in 3D culture","volume":"9","author":"R Herr","year":"2011","journal-title":"Cell Commun Signal"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3324\/haematol.11194","article-title":"The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells","volume":"92","author":"AF Santidrian","year":"2007","journal-title":"Haematologica"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbadis.2007.12.001","article-title":"TSPO over-expression increases motility, transmigration and proliferation properties of C6 rat glioma cells","volume":"1782","author":"M Rechichi","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2174\/138945011795529047","article-title":"The adenine nucleotide translocase 2, a mitochondrial target for anticancer biotherapy","volume":"12","author":"O Sharaf el dein","year":"2011","journal-title":"Curr Drug Targets"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4093\/kdj.2010.34.3.146","article-title":"Adenine nucleotide translocator as a regulator of mitochondrial function: implication in the pathogenesis of metabolic syndrome","volume":"34","author":"EH Kim","year":"2010","journal-title":"Korean Diabetes J"},{"key":"ref38","first-page":"4661","article-title":"Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells","volume":"41","author":"A Floridi","year":"1981","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e24075","DOI":"10.1371\/journal.pone.0024075","article-title":"Therapeutic efficacy and safety of paclitaxel\/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer","volume":"6","author":"L Milane","year":"2011","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1038\/sj.onc.1204953","article-title":"Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437","volume":"20","author":"AS Belzacq","year":"2001","journal-title":"Oncogene"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1202625","article-title":"Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore","volume":"18","author":"L Ravagnan","year":"1999","journal-title":"Oncogene"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2007-1014425","article-title":"Pilot study of PK 11195, a selective ligand for the peripheral-type benzodiazepine binding sites, in inpatients with anxious or depressive symptomatology","volume":"24","author":"M Ansseau","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/bjc.1989.51","article-title":"Phase II study of lonidamine in metastatic breast cancer","volume":"59","author":"P Pronzato","year":"1989","journal-title":"Br J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0071258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:04:08Z","timestamp":1589007848000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0071258"}},"subtitle":[],"editor":[{"given":"John P.","family":"Lydon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0071258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]}}}